Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial

BACKGROUND: Cotrimoxazole (CTX) preventive therapy (CPT) reduces opportunistic infections and malaria in HIV-infected patients. In Africa, policies on sustained CPT during antiretroviral therapy (ART) differ between countries. We assessed the safety of discontinuing CPT in stable patients on ART in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Anywaine, Zacchaeus, Levin, Jonathan, Kasirye, Ronnie, Lutaakome, Joseph Kayiira, Abaasa, Andrew, Nunn, Andrew, Grosskurth, Heiner, Munderi, Paula
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312229/
https://ncbi.nlm.nih.gov/pubmed/30596666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206907
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars